ZBIO

ProShares UltraPro Short NASDAQ Biotechnology

Delisted

ZBIO was delisted on the 27th of March, 2020.

7 hedge funds and large institutions have $1.32M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
4
Closed
1
Calls
Puts
$317K
Net Calls
-$317K
Net Calls Change
-$317K
Name Holding Trade Value Shares
Change
Shares
Change %
VF
1
Virtu Financial
New York
$725K +$493K +27,310 +213%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$363K +$184K +10,173 +102%
Jane Street
3
Jane Street
New York
$213K -$141K -7,844 -40%
Simplex Trading
4
Simplex Trading
Illinois
$6K -$13.6K -811 -69%
UBS Group
5
UBS Group
Switzerland
$5K -$26.9K -1,397 -84%
CG
6
Cutler Group
California
$4K +$4K +263 New
TRCT
7
Tower Research Capital (TRC)
New York
-$32K -1,535 Closed